Dr. Tsimberidou on the Personalized Medicine Results

Video

Dr. Apostolia M. Tsimberidou from MD Anderson Cancer Center on the Personalized Medicine Study Results

Lead author Apostolia M. Tsimberidou, MD, PhD, of the University of Texas MD Anderson Cancer Center, believes that personalized medicine is the future of cancer care and focused on it in a phase I clinical trial conducted at MD Anderson Cancer Center.

The study examined cancer molecular analysis and used matched targeted therapy unique to the aberrations found in the analysis as a way to improve the outcomes of patients. The trial demonstrated that looking at particular genetic abnormalities to select treatment is associated with improved outcomes overall.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD